Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/34840
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | FELIP, E. | |
dc.contributor.author | CASTRO, G. | |
dc.contributor.author | GREYSTOKE, A. | |
dc.contributor.author | SOLOMON, B. | |
dc.contributor.author | TAN, D. | |
dc.contributor.author | PASSOS, V. | |
dc.contributor.author | DEUDON, S. | |
dc.contributor.author | LOUVEAU, A. | |
dc.contributor.author | JOHNSON, B. | |
dc.date.accessioned | 2020-02-03T17:21:21Z | - |
dc.date.available | 2020-02-03T17:21:21Z | - |
dc.date.issued | 2019 | |
dc.identifier.citation | JOURNAL OF THORACIC ONCOLOGY, v.14, n.10, suppl.S, p.S645-S645, 2019 | |
dc.identifier.issn | 1556-0864 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/34840 | - |
dc.language.iso | eng | |
dc.publisher | ELSEVIER SCIENCE INC | eng |
dc.relation.ispartof | Journal of Thoracic Oncology | |
dc.rights | restrictedAccess | eng |
dc.subject | IL-1 beta | eng |
dc.subject | Canakinumab | eng |
dc.subject | NSCLC | eng |
dc.title | CANOPY-1: Phase 3 Study of Canakinumab/Placebo plus Pembrolizumab plus Platinum-Chemotherapy in Untreated Stage IIIB-IV NSCLC Pts | eng |
dc.type | conferenceObject | eng |
dc.rights.holder | Copyright ELSEVIER SCIENCE INC | eng |
dc.identifier.doi | 10.1016/j.jtho.2019.08.1361 | |
dc.subject.wos | Oncology | eng |
dc.subject.wos | Respiratory System | eng |
dc.type.category | meeting abstract | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.author.external | FELIP, E.:Vall DHebron Inst Oncol, Barcelona, Spain | |
hcfmusp.author.external | GREYSTOKE, A.:Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England | |
hcfmusp.author.external | SOLOMON, B.:Peter Maccallum Canc Ctr, Melbourne, ACT, Australia | |
hcfmusp.author.external | TAN, D.:Natl Canc Ctr Singapore, Singapore, Singapore | |
hcfmusp.author.external | PASSOS, V.:Novartis Pharmaceut, E Hanover, NJ USA | |
hcfmusp.author.external | DEUDON, S.:Novartis Pharma Ag, Basel, Switzerland | |
hcfmusp.author.external | LOUVEAU, A.:Novartis Pharma Sas, Rueil Malmaison, France | |
hcfmusp.author.external | JOHNSON, B.:Dana Farber Canc Inst, Boston, MA 02115 USA | |
hcfmusp.description.beginpage | S645 | |
hcfmusp.description.endpage | S645 | |
hcfmusp.description.issue | 10 | |
hcfmusp.description.issue | suppl S | |
hcfmusp.description.volume | 14 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.id | WOS:000492162203276 | |
hcfmusp.publisher.city | NEW YORK | eng |
hcfmusp.publisher.country | USA | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.eissn | 1556-1380 | |
Appears in Collections: | Comunicações em Eventos - FM/MDR Comunicações em Eventos - HC/ICESP Comunicações em Eventos - LIM/24 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.